Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.8557
-0.0713 (-7.69%)
At close: Nov 17, 2026, 4:00 PM EST
0.8557
0.00 (0.00%)
After-hours: Nov 17, 2026, 4:00 PM EST
Matinas BioPharma Holdings Employees
Matinas BioPharma Holdings had 2 employees as of December 31, 2025. The number of employees decreased by 1 or 33.33% compared to the previous year. That makes Matinas BioPharma Holdings the 43,436th largest employer in the world and 6,975th in the United States.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,771,000
Market Cap
838.17K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | -1 | -33.33% |
| Dec 31, 2024 | 3 | -29 | -90.63% |
| Dec 31, 2023 | 32 | -2 | -5.88% |
| Dec 31, 2022 | 34 | 3 | 9.68% |
| Dec 31, 2021 | 31 | 11 | 55.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PMGC Holdings | 34 |
| GeoVax Labs | 19 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| SciSparc | 3 |
| Oragenics | 3 |
| Bone Biologics | 2 |
| Endovia Health Sciences | 2 |
MTNB News
- 1 day ago - Matinas BioPharma Holdings Quarterly report: Q3 2026 - Filings
- 2 months ago - GH Power Signs Multi-Year Hydrogen Offtake Agreement with Change Energy for Hamilton Facility Output - GlobeNewsWire
- 2 months ago - Matinas BioPharma receives noncompliance notifcation from NYSE - TheFly
- 2 months ago - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 3 months ago - Matinas BioPharma Holdings Quarterly report: Q2 2026 - Filings
- 4 months ago - Matinas BioPharma teams with GH Power to create publicly-traded company - TheFly
- 4 months ago - Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals - GlobeNewsWire
- 4 months ago - Matinas BioPharma receives noncompliance notification from NYSE - TheFly